MedTrace Logo

Early Ageing During Therapy in AYA Cancer Patients

NCT05062707 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2025-05-13

No results posted yet for this study

Summary

Longitudinal cohort study; measurements before start of systemic therapy and one year later.

Conditions

Interventions

PROCEDURE

Blood sampling

Study measurements will be performed twice and consist of blood withdrawal and physical examination (weight, height, waist-hip ratio, and blood pressure).

Sponsors & Collaborators

  • UMCG Kanker Researchfonds

    collaborator UNKNOWN

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • J. Nuver, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-10
Primary Completion
2025-07-31
Completion
2025-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05062707 on ClinicalTrials.gov